Inflammation and Anti-Inflammatory Therapies for Cystic Fibrosis
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 28 (2) , 331-346
- https://doi.org/10.1016/j.ccm.2007.02.002
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosisAnnals of Allergy, Asthma & Immunology, 2005
- Neutrophil cell death, activation and bacterial infection in cystic fibrosisThorax, 2005
- A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalitiesThe Journal of Pediatrics, 2001
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosisThe Journal of Pediatrics, 1996
- PPAR: a mediator of peroxisome proliferator actionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1995
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjectsThe Journal of Pediatrics, 1994